Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
340B Report

340B Report

Category: Non-Governmental

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

In Federal, Non-Governmental, Pharma Industry, RegulatoryOctober 15, 2020 Tom Mirga
SPONSORED BY


…

Read More »

340B Experts Welcome HRSA’s Policy Clarifications on Hospital Child Sites and Telemedicine

In Federal, Non-Governmental, RegulatoryJune 11, 2020 Tom Mirga
SPONSORED BY


Happy

…
Read More »

COVID-19 Casts a Shadow Over 340B-Related Meetings, Including the Year’s Main Event

In Non-Governmental, Trade AssociationApril 21, 2020 Tom Mirga
SPONSORED BY


…

Read More »

Think Tank to States: Use 340B to Reduce Drug Prices

In Non-Governmental, Research/Reports, StateFebruary 14, 2020 Tom Mirga

Think Tank to States: Use 340B to Reduce Drug Prices

States should do more to help hospitals and other providers enroll in the 340B program as a way to lower drug prices, a liberal think tank with ties to the

…
Read More »

Another New Study of Differences in Cancer Drug Spending Could Have 340B Implications

In Non-Governmental, Research/ReportsFebruary 7, 2020 Tom Mirga

Another New Study of Differences in Cancer Drug Spending Could Have 340B Implications

On Friday, the nonpartisan Medicare Payment Advisory Commission (MedPAC) made headlines (see story below) when its staff said it could find no link between evidence of 340B

…
Read More »

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Test-Memberful
  • Trade Association
  • Uncategorized

Recent Posts

  • Important Information About Accessing 340B Report
  • Health Centers File 340B Dispute Resolution Petitions Against Drug Manufacturers
  • Lilly Asks Court to Shield it From “Crippling” 340B Sanctions
  • Nevada ADAP Postpones Controversial 340B Policy Change
  • Top 10 Issues to Consider in 2021

Site Footer

Terms of Use Privacy Policy